Abko Co., Ltd. Overview
ABKO is a Korean fabless-style designer and marketer of PC peripherals and gaming gear that has evolved into a two-legged business: a consumer/PC-bang (internet café) gaming-gear franchise sold under the ABKO, HACKER, COX and NCORE brands, and a public-procurement business anchored by PADBANK, an IoT charging-and-storage cabinet for classroom tablets and laptops, in which the company claims roughly 70% domestic share and an installed base of about 120,000 classroom units [S3]. A small-appliance line (OHELLA) has been de-emphasised since 2022 [S35]. After a pandemic-era collapse from a FY2020 peak (revenue KRW 153.2 bn, operating profit KRW 23.5 bn) to losses in FY2021–FY2022, ABKO restored modest profitability from FY2023 but has not regained growth (FY2025 revenue KRW 83.4 bn) [S9][S12]. In 2025–2026 management pivoted to capital return (≈17–19% yield special dividend, share cancellation) and to an unrelated medical-AI bet via a 40% stake in US start-up Bullseye Biodevices [S1][S6].
Company self-description. Korean financial databases that summarise ABKO's business report describe the company as operating in three fields — gaming gear, small household appliances, and public business. Gaming gear (keyboards, headsets, mice, monitors and other PC peripherals) is sold under the ABKO, HACKER, COX and NCORE brands, supported by a cost- and quality-control system and directly operated service centres; small appliances are planned under the OHELLA brand (kitchen and pet-related products); and the public business supplies IoT charging cabinets for schools (PADBANK), unmanned collection bins and AI servers to public procurement channels, while developing peripherals for digital-textbook programmes [S13][S14]. Morningstar's summary adds that the company has supplied tablet charging stations for the government-led digital textbook project [S40].
Independent characterisation. ABKO is best understood as a branded, asset-light hardware marketer with outsourced manufacturing (predominantly Chinese ODM/OEM supply chains is the typical model for Korean peripheral brands; the specific manufacturing split is not publicly disclosed in sources reviewed) and an in-house design, quality-control, logistics and after-sales capability. Its competitive moat in gaming gear historically rested on the Korean PC-bang channel, where the company claimed roughly 80% share for PC-bang gaming gear (driven by fully waterproof keyboards and fast A/S) as of early 2022 [S26]. The PADBANK business is a B2G (business-to-government) tender business whose revenue follows provincial education-office budgets, which creates lumpy, policy-dependent revenue but carries meaningful reference-based barriers to entry (sole supplier in the government's smart-school pilots 1–4; 9,347 units to 5,577 schools by late 2021) [S28].
Revenue model. Revenue is almost entirely product sales (one-time hardware). There is no material subscription or licensing revenue disclosed. PADBANK includes IoT app functions (timer, charge monitoring, power control) [S16], but no separately monetised software/service line is disclosed.
Value-chain position. Design/specification → contract manufacturing (outsourced; not detailed) → import/logistics (Gimpo logistics capability; one Gimpo logistics centre sold in 2025–26 [S1]) → distribution through online marketplaces (Coupang, Naver, Gmarket, 11st, SSG, Kakao Gift, etc.), 600+ big-box stores (E-mart, Homeplus, Lotte Hi-mart, Costco, Traders, as of June 2023) [S22], PC-bang channel, export distributors, and public tenders → after-sales service (direct service centres; PADBANK A/S through 20 regional branches per Korea IR Council) [S19].
Customer types and end-markets.
Strategy
Stated strategy themes (paraphrased from company statements).
-
Core-business profitability over growth. Since 2023 management has prioritised high-margin products, inventory discipline and cost restructuring in gaming gear [S15][S17].
-
Public business as cash engine. Management and Korea IR Council position PADBANK as a cash cow supported by new-school deployments, the 2018-cohort replacement cycle and private-education sales [S3][S19].
-
Overseas expansion. Ongoing efforts to broaden overseas channels to offset domestic volatility; Q1 2026 exports grew YoY [S2]; PADBANK export pilots in Europe/SE Asia [S30].
-
Premium PC-bang marketing. Targeting demand from premium PC-bangs; ABKO products named Q1 2026 hit products by a PC-bang trade outlet [S2].
-
Diversification into medical AI. Stated intent to apply electronics design, manufacturing and sales capabilities to biosensors via Bullseye and to diversify growth drivers [S4][S5].
-
Shareholder returns. Treasury-share purchases (2024), cancellation (2025) and a large reserve-funded dividend (2025) [S1][S20].
Strategic initiatives — last 24 months
Medium-term targets / guidance. ABKO does not publish formal financial guidance. Qualitative statements include the CEO's expectation (interview, undated, c. 2024) of 20–30% domestic PADBANK sales growth over the next few years and significant overseas growth [S30]. ESG/sustainability commitments: not publicly disclosed beyond the disabled-persons workplace subsidiary.
Products & Services
Pricing is generally not disclosed by the company; retail prices below are point-in-time marketplace observations and are flagged as such.
Gaming Gear segment
| Product line / brand | Representative product | Description / key specifications | Target customer | Year / version | Pricing (observed) | Source |
|---|---|---|---|---|---|---|
| ABKO keyboards | AK998 8K | Wired 98-key mechanical keyboard; custom Otemu switches (silent Peach v3 / Melon linear variants); gasket mount with multi-layer foam; double-shot PBT keycaps; hot-swap; rotary knob; 8,000 Hz polling | Enthusiast home gamers | Reviewed Jan–Feb 2025 | — | [S45] |
| ABKO keyboards (collab) | AF108PRO ABKO x SOAI | 3-mode (wired/2.4 GHz/Bluetooth) mechanical keyboard in multiple switch and colour variants | Consumer / lifestyle gamers | Listed on KREAM official brand store | — | [S45] |
| HACKER | Gaming keyboards, mice, headsets | Flagship gaming-gear sub-brand; waterproof PC-bang keyboards historically central | PC-bang operators, gamers | Ongoing | — | [S22][S25][S26] |
| COX | Gaming keyboards, mice | Second gaming-gear brand; mechanical keyboards (incl. "retro" designs credited with FY2023 margin recovery) | Enthusiast gamers | Ongoing | — | [S17][S22] |
| NCORE | PC cases, cooling, laptop cooling pads | e.g., NCORE NC30 notebook cooling pad | Consumer | Ongoing | approx. KRW 24,000 (Coupang listing) | [S45] |
| ABKONCORE (export brand) | A900 mouse | Ambidextrous mouse, PixArt PMW3389 sensor up to 16,000 CPI, Omron 20M switches, RGB, software | Western gamers | Reviewed by TechPowerUp | USD 32.99 (at review) | [S44] |
| Wireless office mice | WM600 | Silent wireless mouse | Office/home users | 2024 review | approx. KRW 10,000–19,999 range (reviewer) | [S45] |
| Gaming headsets | Ultralight gaming headsets | Lightweight headsets cited as a high-margin driver in FY2023 | Gamers | FY2023 | — | [S17] |
| Gaming chairs | AGC21 | Premium gaming chair with footrest | Consumers (incl. export, Hong Kong) | Ongoing | HK$1,588 (YOHO listing) | [S45] |
| Licensed editions | Diablo II: Resurrected (4 SKUs: Cherry-switch RGB keyboards full/TKL, lightweight wireless mouse, 7.1 RGB headset); Black Desert (keyboard, mouse) | Official licensed gaming gear with Blizzard and Pearl Abyss IP | Gamers, export B2B | 2021–2022 | — | [S25][S26] |
| Other PC peripherals | Cases, PSUs, CPU coolers, fans, webcams, monitor stands, cables, mousepads, monitors, gaming laptops/monitors (diversification announced 2021) | Broad peripheral catalogue | Consumers, PC builders | Ongoing | — | [S27][S38][S43] |
Public Business segment
| Product | Description / capabilities | Target customer | Launch / status | Pricing | Source |
|---|---|---|---|---|---|
| PADBANK (education) | Charging and storage cabinet for classroom tablets, laptops, Chromebooks and Whale books; batch content sync from a master PC; overcharge protection; auto-charge; IoT app with timer, monitoring and power control; company claims sole domestic CE certification among cabinets above 1 kVA; sterilisation module claimed as the only domestic FDA medical-device-class registered unit | Provincial education offices, K-12 schools | Launched 2014; ≈120,000 classroom units cumulative by May 2026 | Tender-based; not disclosed | [S3][S16][S28] |
| PADBANK (commercial) | Same platform for commercial tablet fleets | Automotive production lines, universities, apparel stores, cafés | Expansion announced Sep 2023 | — | [S21] |
| PADBANK (export) | Pilot tests in overseas markets; Europe the focus, with Indonesia and Thailand in discussion | Foreign education ministries | In development (per CEO interview) | — | [S30] |
| Unmanned collection bins | Public-sector unmanned recycling/collection units | Municipalities, public bodies | Listed in 2026 business description | — | [S13] |
| AI servers | AI server hardware supplied via public procurement | Public institutions | Listed in 2026 business description | — | [S13] |
| Digital-textbook peripherals | Peripherals for digital textbook programmes | Schools | In development | — | [S13] |
| LED signage (ABKO Public) | LED information signboards and displays manufactured by disabled-persons standard workplace subsidiary | Public / institutional | Ongoing | — | [S3] |
Small Appliances segment
| Brand | Products | Status | Source |
|---|---|---|---|
| OHELLA | Kitchen appliances (multi-cooker highlighted in 2024), pet-related products; earlier: soap dispensers, bathroom cleaners, silicone facial brushes, LED motion-sensor lights, LED desk/monitor lamps, cordless massage guns | Being scaled down since 2022 due to losses; selective channel expansion (home shopping, duty-free, bookstores) | [S13][S18][S22][S35][S38] |
New business (2026)
| Initiative | Description | Status | Source |
|---|---|---|---|
| Bullseye Biodevices (≈40% associate) | Biosensor mounted on surgical robots to measure electrical, optical and mechanical bio-signals at the surgical site, combined with AI analysis for real-time quantitative tissue assessment; patents include a non-destructive pressure-assisted tissue-stiffness measurement device for tumour detection and a robot-based lung endoscope system for targeted drug delivery | Pre-commercial; FDA-oriented clinical development with Stanford medical school (per Edaily summary) | [S4][S7][S8] |
Financial Narrative
Basis of preparation. OpenDART data compiled by Bullstory indicate FY2020 and FY2023–FY2025 are consolidated statements, while FY2021–FY2022 figures in that compilation are on a separate (parent-only) basis [S9]. Asia Economy, however, reported FY2021 revenue of KRW 101.8 bn as a consolidated figure [S26]. Given ABKO's small subsidiary footprint, the difference is likely immaterial, but the series is not strictly like-for-like.
Income statement
Sources: [S9][S11][S12]; margins derived. FY2025 exact OpenDART values: revenue KRW 83,427,579,554; operating income KRW 3,176,674,216; net income KRW 6,409,461,559 [S10].
Pre-period history (KRW bn)
Sources: [S31][S33][S34].
Revenue CAGR (derived): FY2021–FY2025 −4.9% p.a.; FY2020–FY2025 −11.4% p.a.
Gross profit, EBITDA, pre-tax income, EPS. Gross profit was located only for FY2022: revenue KRW 82.7 bn, cost of revenue KRW 79.7 bn, gross profit KRW 3.0 bn (gross margin ≈3.6%, depressed by inventory clearance) [S38]. FY2022 G&A expense was KRW 15.3 bn and R&D KRW 0.76 bn [S38]. EBITDA, pre-tax income, and annual basic/diluted EPS for FY2021–FY2025 are not publicly disclosed in the sources reviewed. Trailing EPS is KRW 115 (Valueline, LTM to 2Q26) [S13]; Investing.com reported TTM EPS of KRW −352 in early 2026, which appears inconsistent with reported FY2025 profits and is likely a stale or pre-split data artefact [S39]. Q1 2026 EPS was KRW 61.60 [S39].
Quarterly data points
n/d = not publicly disclosed in sources reviewed. 1H2026 totals: H1 report filed 14 Aug 2026 [S11]; headline figures not located.
Cash flow: notes and sources
Source: [S9]. Capex, free cash flow and dividends paid by year are not publicly disclosed in sources reviewed. Known capital-return cash items: KRW 3.0 bn buyback programme (Apr–Oct 2024) [S20]; treasury-share cancellation of ≈KRW 6.8 bn book value (Oct–Nov 2025; a non-cash retirement of previously acquired shares) [S12]; dividend of ≈KRW 7.9 bn declared Dec 2025 [S12]. Known capital investments: Gimpo second logistics centre (completion planned Mar 2025) [S15] and a Gimpo PADBANK production facility (targeted Q2 completion, year not specified in source) [S30]. Known disposal inflow: ≈KRW 8.0 bn Gimpo logistics centre sale, balance due 30 Jan 2026 [S1].
Commentary on trends, inflections and drivers
FY2020 peak and FY2021–FY2022 collapse. FY2020 was an outlier, boosted by pandemic home-gaming demand, small-appliance sales and the first scaled smart-school orders; revenue nearly doubled to KRW 153.2 bn and operating margin reached ≈15% [S33][S34]. Sell-side forecasts at the time projected FY2021 revenue of KRW 215–251 bn [S32][S34]; actual FY2021 revenue was KRW 101.8 bn. Management attributed the reversal to operating-hour restrictions on PC-bangs (its largest domestic channel) and GPU shortages caused by crypto mining, which depressed gaming-PC builds and therefore peripheral replacement [S26][S27]. FY2022 was the trough: a gross margin of only ≈3.6% indicates heavy inventory write-downs or clearance pricing, and the net loss widened to KRW 17.6 bn [S9][S38].
FY2023 turnaround. Revenue recovered 19.7% to KRW 98.9 bn with a return to operating profit (KRW 2.2 bn). Management credited exhaustion of long-dated inventory, higher-margin products (ultralight headsets, retro mechanical keyboards, gaming mice) and PADBANK demand from the Green Smart School policy [S17]. Mirae Asset framed FY2023 as the "first year of structural improvement" in a December 2023 note [S37].
FY2024–FY2025: profitable but shrinking. Operating profit peaked at KRW 4.8 bn in FY2024 on cost restructuring (management cited "continuous innovation in manpower and cost structure") [S15], but revenue declined in both years. Two features stand out. First, cash generation is volatile and driven by working capital in the tender business: OCF was −KRW 8.2 bn in FY2024 despite KRW 4.7 bn net income, then +KRW 11.1 bn in FY2025 [S9]. Second, FY2025 net income (KRW 6.4 bn) exceeded operating income (KRW 3.2 bn), and Q1 2026 net income (KRW 2.8 bn) was four times operating income (KRW 0.7 bn) [S2][S10], implying material non-operating gains. The specific items are not disclosed in sources reviewed; the timing is consistent with financial income and/or the Gimpo logistics centre sale (balance due Jan 2026), but this is an analyst inference.
Quality of earnings. Simply Wall St published a note titled to the effect that ABKO's profits appear to have quality issues (March, year not shown) [S38]. Combined with the NI > OP pattern, investors should treat headline net income and the LTM P/E of ~7.9x with caution; on an operating basis (LTM operating income KRW 1.8 bn to Q1 2026 [S14]), the equity trades at roughly 24x operating profit.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment (%)
| Segment (% of revenue) | FY2022 | FY2023 | 1H2026 |
|---|---|---|---|
Gaming gear (incl. export) | 70.5 | 53.0 | 57.0 |
Public business (PADBANK etc.) | 22.5 | 41.6 | 43.0 |
Small appliances | 7.1 | 5.4 | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment revenue (KRW Bn, derived)
| Segment revenue (KRW Bn, derived) | FY2022 | FY2023 |
|---|---|---|
Gaming gear | 58.3 | 52.4 |
Public business | 18.6 | 41.1 |
Small appliances | 5.9 | 5.3 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 101.8 | 82.7 | 98.9 | 93.4 | 83.4 |
Operating income (KRW Bn) | -9.2 | -15.5 | 2.2 | 4.8 | 3.2 |
Net income (KRW Bn) | -7.1 | -17.6 | 1.8 | 4.7 | 6.4 |
Revenue growth YoY (%) | -33.5 | -18.8 | 19.7 | -5.6 | -10.6 |
Operating margin (%) | -9.0 | -18.7 | 2.2 | 5.1 | 3.8 |
Net margin (%) | -7.0 | -21.3 | 1.8 | 5.0 | 7.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement
| Metric | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
Revenue (KRW Bn) | 66.3 | 84.3 | 153.2 |
Operating income (KRW Bn) | 3.8 | 5.5 | 23.5 |
Net income (KRW Bn) | 2.6 | 3.5 | 18.2 |
Export revenue (KRW Bn) | 3.0 | 3.9 | 9.6 |
Revenue History
| Quarter | Revenue | Operating income | Net income | Basis / source |
|---|---|---|---|---|
Q1 2021 | 42.6 | 3.7 | 3.2 | Reported [S29] |
Q3 2021 | 20.8 | -4.4 | -4.4 | Reported [S27] |
Q1 2024 | 22.0 | 2.7 | — | Derived: 1H24 (35.3 / 3.1) less Q2 [S15] |
Q2 2024 | 13.3 | 0.45 | — | Reported [S15] |
Q1 2025 | ≈23.0 | ≈2.1 | ≈2.1 | Derived from LTM data and Q1 2026 growth rate [S2][S14] |
Q1 2026 | 16.4 | 0.7 | 2.8 | Reported [S2] |
LTM to Q1 2026 | 76.8 | 1.8 | — | Valueline [S14] |
Financial Analysis
| Item | Value | Basis / source |
|---|---|---|
Book value per share (LTM 2Q26) | KRW 1,234 | [S13] |
Shareholders' equity (derived) | ≈KRW 56.2 bn | BPS × 45.55m shares |
Post-IPO paid-in capital (Dec 2020) | KRW 4.8 bn | [S31] |
Capital reserve transferred to retained earnings (2023) | KRW 33.0 bn | [S21] |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Bn) | 15.5 | -14.6 | 15.4 | -8.2 | 11.1 |
Net income (KRW Bn) | -7.1 | -17.6 | 1.8 | 4.7 | 6.4 |
Financial Analysis — ROE
| Ratio | Value |
|---|---|
ROE (LTM) | 9.7% |
5-year average ROE | -2.41% |
P/E (LTM) | 7.9x |
P/B | 0.77x |
P/S | 0.53x |
EV/EBITDA | 15.4x |
Dividend payout (TTM) | ≈155% of EPS (Investing.com) |
Geographic Revenue
| Category | LTM to Q1 2026 (KRW Bn) | Share (%) |
|---|---|---|
Domestic (내수) | 60.7 | 79.0 |
Export (수출) | 2.3 | 2.9 |
Other (기타) | 15.9 | 20.7 |
Total revenue | 76.8 | 100 |
Revenue by Region
| Metric | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
Export revenue (KRW Bn) | 2.6 | 3.0 | 3.9 | 9.6 |
Valuation Snapshot
| Metric | Value |
|---|---|
Last price referenced | KRW 940 (15 Oct 2026; page shows "trading suspended" flag) |
Market cap | ≈KRW 43.2 bn |
Shares outstanding | ≈45.55 m |
52-week range | KRW 835 – 1,375 |
6-month price change | −11.5% |
1-year price change | ≈+2% to +5% (Investing.com, Jul–Aug 2026 snapshots) |
~5-year change (derived) | ≈−80% vs split-adjusted KRW 4,700 (KRW 23,500 pre-split, 17 May 2021) |
Valuation Multiples
| Multiple | ABKO | Logitech | Corsair |
|---|---|---|---|
P/E (LTM) | 7.9x | Not compiled | Not compiled |
EV/EBITDA | 15.4x | Not compiled | Not compiled |
EV/Sales | Not disclosed (P/S 0.53x) | Not compiled | Not compiled |
P/B | 0.77x | Not compiled | Not compiled |
Dividend History
| Fiscal year | DPS (KRW) | Total (KRW Bn) | Notes |
|---|---|---|---|
FY2025 | 174 | ≈7.9 | Declared 1 Dec 2025; funded from capital reserve; non-taxable to most individual holders; ≈17.5% yield at declaration |
Analyst Conclusions
Management guidance. No quantitative guidance. Qualitative messaging emphasises overseas channel expansion, premium PC-bang demand, PADBANK replacement orders and medical-AI diversification [S2][S3][S5]. Consensus growth expectations: none available.
Bull case
-
PADBANK replacement super-cycle. With ≈120,000 classroom units installed and the 2018 cohort coming due, plus new ≈5,000-unit contracts already signed in 2026, public revenue (43% of 1H2026 sales) could re-accelerate [S3][S11].
-
Deep value with cash returns. At ≈0.77x book and ≈0.53x sales, with a demonstrated willingness to cancel shares and pay a large dividend, the equity offers asymmetric upside if operating profit stabilises at FY2024 levels (KRW 4.8 bn) [S9][S13].
-
Medtech optionality. A 40% stake in an NSF-supported biosensor developer working toward FDA clearance with Stanford provides a low-cost call option on a surgical-robotics market projected at USD 18.5 bn by 2033 [S5][S8].
Bear case
-
Structural shrinkage. Revenue has fallen in two consecutive years and Q1 2026 revenue was down ≈29% YoY (derived), with LTM operating profit just KRW 1.8 bn [S2][S14].
-
Non-recurring returns and earnings quality. The 2025 dividend was funded from capital reserves and exceeds TTM EPS; reported net income has leaned on non-operating items [S2][S12][S13].
-
Capital misallocation risk. Proceeds from selling core logistics assets are being redirected into a pre-revenue US medtech start-up outside the company's competence, at undisclosed valuation [S1][S6].
Key catalysts and monitorables (next 12 months)
-
Confirmation of trading status on KIND (third-party suspension flag) [S13].
-
Q3 2026 results (expected mid-November 2026) and 1H2026 headline figures.
-
PADBANK tender outcomes (Chungnam, Daegu and other education offices) [S3].
-
Bullseye valuation, accounting treatment and clinical/FDA milestones [S6][S8].
-
Any FY2026 dividend decision (December) and further cancellations.
-
Sale of the adjacent Gimpo land parcel [S1].
-
Export trajectory and premium PC-bang demand [S2].
Concluding analyst verdict. ABKO today is a profitable-but-shrinking domestic peripheral and education-hardware company trading at a deep discount to book value, with a controlling shareholder who has recently chosen to return capital aggressively while simultaneously redirecting balance-sheet resources toward an unrelated medical-AI venture. The core franchise is real: PADBANK's ≈70% share and reference base in Korean classrooms is a defensible niche, and the brand portfolio retains domestic relevance in gaming gear. But the financial record since the FY2020 peak is sobering. Revenue has roughly halved, operating margins have been confined to low single digits since FY2023, exports have largely disappeared, and recent net income has depended on non-operating items. The FY2025 dividend, while eye-catching at a ≈17–19% yield, was funded from capital reserves and is not covered by trailing earnings, so investors should treat it as a one-off capital distribution rather than a recurring yield. The Bullseye investment converts part of the asset base into an illiquid, pre-revenue minority stake whose valuation has not been disclosed; it may prove valuable, but it adds governance and impairment risk and signals that management sees limited reinvestment opportunity in its core businesses. On balance, the equity's appeal rests on three things: the size and timing of the PADBANK replacement cycle, management discipline in further capital returns, and evidence that Bullseye can progress clinically. Absent visible revenue stabilisation in 2H2026 and clarity on the reported trading-status flag, the risk-reward appears balanced at best, with the low P/B multiple reflecting genuine earnings-quality and capital-allocation concerns rather than a pure mispricing.
| Item | Status |
|---|---|
| ISIN, auditor, full board and C-suite, executive compensation | — |
| Gross profit (except FY2022), EBITDA, pre-tax income, annual EPS FY2021–FY2025 | — |
| Total assets, cash, debt split, net debt, goodwill, working capital | — |
| Capex, free cash flow, dividends paid by year | — |
| Segment revenue FY2024–FY2025; segment operating income | — |
| Geographic split beyond domestic/export | — |
| R&D spend except FY2022; patent count | — |
| Bullseye deal value | — |
| Top-10 shareholders (current) | — |
| Current trading status | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / education / age | Compensation |
|---|---|---|---|---|
Oh Kwang-geun (오광근) | CEO / Representative Director; largest shareholder | CEO at least since IPO (2020); start date not disclosed | — | Not publicly disclosed (Korean rules require individual disclosure only above KRW 500 m) |
Board of directors | — | — | Composition, independence, committees not publicly disclosed in sources reviewed | — |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake | Date |
|---|---|---|
Largest shareholder and related parties (post-IPO) | 40.2% + 16.2% special related parties/employees | Nov 2020 (IPO prospectus basis) |
Oh Kwang-geun and 8 related parties | 54.19% | May 2021 |
Foreign ownership | 5.47% | May 2021 |
Competitive Landscape
Peer Comparison FY2025
| Company | Fiscal year | Revenue | Revenue growth | Profitability metric | R&D intensity |
|---|---|---|---|---|---|
ABKO | FY2025 (Dec) | KRW 83.4 bn | -10.6% | Operating margin 3.8%; net margin 7.7% | ≈0.9% (FY2022 only) |
Logitech International | FY2026 (Mar) | USD 4.84 bn | +6% | GAAP operating income USD 775 m (≈16.0% margin, derived); net income USD 711.2 m; non-GAAP gross margin 43.6% | Not compiled |
Corsair Gaming | FY2025 (Dec) | USD 1,472.5 m | +12% | GAAP gross margin 28.9%; adjusted EBITDA USD 100.6 m | Not compiled |
Jooyon Tech (KOSDAQ peer) | FY2025 (Dec) | KRW 62.6 bn | Not compiled | Operating loss KRW 1.7 bn (≈−2.7%) | Not compiled |
Recent Developments
Litigation, regulatory actions, layoffs, or leadership changes in the window: none identified in sources reviewed.



